Novo Nordisk is warned by the FDA for failing to report side effects

Updates

Update at 13:29 UTC on 2026-03-11

STAT reported Recent developments highlight the FDA's warning to Novo Nordisk and Lilly's strategic investments in China.

Sources: STAT